Neutrophil-to-lymphocyte ratio predicts early acute cellular rejection in living donor liver transplantation
- PMID: 33304861
- PMCID: PMC7704271
- DOI: 10.4174/astr.2020.99.6.337
Neutrophil-to-lymphocyte ratio predicts early acute cellular rejection in living donor liver transplantation
Abstract
Purpose: The aim of this study was to evaluate the predictive value of neutrophil-to-lymphocyte ratio (NLR) in acute cellular rejection (ACR) after living donor liver transplantation (LDLT).
Methods: All consecutive patients who underwent ABO-compatible (ABOc) LDLT from September 2014 to December 2017 were retrospectively reviewed. NLR was calculated on 3 occasions; (1) 4 weeks prior to liver transplantation (LT), (2) the day of LT, and (3) the day before liver biopsy.
Results: Among 66 patients who underwent ABOc LDLT, ACR was identified in 15 patients (22.7%) on protocol liver biopsy performed routinely on the postoperative day 7. There was no significant difference in NLR at 4 weeks prior to LT and the day of LT between no-ACR and ACR group (2.98 ± 1.92 vs. 2.54 ± 1.15, P = 0.433; 17.9 ± 8.31 vs. 20.5 ± 13.4, P = 0.393). However, NLR was significantly lower in ACR group compared to non-ACR group just prior to liver biopsy (5.82 ± 3.42 vs. 18.4 ± 17.2, P = 0.035). NLR tends to decrease 3.5 days before the onset of ACR. The area under the receiver operating characteristic curve for optimal cut-off value of NLR was 6.49, with sensitivity and specificity of 80.4% and 73.3% respectively.
Conclusion: NLR has a potential as a noninvasive predictor of early ACR in ABOc LDLT.
Keywords: Liver transplantation; Lymphocytes; Neutrophils; Rejection.
Copyright © 2020, the Korean Surgical Society.
Conflict of interest statement
Conflict of Interest: No potential conflict of interest relevant to this article was reported.
Figures
References
-
- Maluf DG, Stravitz RT, Cotterell AH, Posner MP, Nakatsuka M, Sterling RK, et al. Adult living donor versus deceased donor liver transplantation: a 6-year single center experience. Am J Transplant. 2005;5:149–156. - PubMed
-
- Gruttadauria S, Vasta F, Mandalà L, Cintorino D, Piazza T, Spada M, et al. Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation. Transplant Proc. 2005;37:2611–2613. - PubMed
-
- Emond JC, Rouch D, Thistlethwaite J, Whitington P, Baker A, Ferrari M, et al. Rejection in liver allograft recipients: clinical characterization and management. Clin transplant. 1987;1:143–150.
-
- Soin AS, Rasmussen A, Jamieson NV, Watson CJ, Friend PJ, Wight DG, et al. CsA levels in the early posttransplant period: predictive of chronic rejection in liver transplantation? Transplantation. 1995;59:1119–1123. - PubMed
-
- Neil DA, Hubscher SG. Delay in diagnosis: a factor in the poor outcome of late acute rejection of liver allografts. Transplant Proc. 2001;33:1525–1526. - PubMed
LinkOut - more resources
Full Text Sources
